Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The efficacy and safety of etanercept when used with as-needed adjunctive topical therapy in a randomised, double-blind study in subjects with moderate-to-severe psoriasis (the PRISTINE trial).
Strohal R, Puig L, Chouela E, Tsai TF, Melin J, Freundlich B, Molta CT, Fuiman J, Pedersen R, Robertson D. Strohal R, et al. J Dermatolog Treat. 2013 Jun;24(3):169-78. doi: 10.3109/09546634.2012.658015. Epub 2012 Feb 23. J Dermatolog Treat. 2013. PMID: 22251226 Free article. Clinical Trial.
Cardiometabolic profile, clinical features, quality of life and treatment outcomes in patients with moderate-to-severe psoriasis and psoriatic arthritis.
Puig L, Strohal R, Husni ME, Tsai TF, Noppakun N, Szumski A, Yang S, Robertson D, Boggs R, Koenig AS. Puig L, et al. Among authors: strohal r. J Dermatolog Treat. 2015 Feb;26(1):7-15. doi: 10.3109/09546634.2013.860209. Epub 2013 Nov 27. J Dermatolog Treat. 2015. PMID: 24283931 Free article. Clinical Trial.
Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasis.
Strohal R, Kirby B, Puig L; Psoriasis Expert Panel; Girolomoni G, Kragballe K, Luger T, Nestle FO, Prinz JC, Ståhle M, Yawalkar N. Strohal R, et al. J Eur Acad Dermatol Venereol. 2014 Dec;28(12):1661-9. doi: 10.1111/jdv.12350. Epub 2013 Dec 24. J Eur Acad Dermatol Venereol. 2014. PMID: 24372845 Free PMC article.
Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial.
Bachelez H, van de Kerkhof PC, Strohal R, Kubanov A, Valenzuela F, Lee JH, Yakusevich V, Chimenti S, Papacharalambous J, Proulx J, Gupta P, Tan H, Tawadrous M, Valdez H, Wolk R; OPT Compare Investigators. Bachelez H, et al. Among authors: strohal r. Lancet. 2015 Aug 8;386(9993):552-61. doi: 10.1016/S0140-6736(14)62113-9. Epub 2015 Jun 4. Lancet. 2015. PMID: 26051365 Clinical Trial.
Recommendations for the use of etanercept in psoriasis: a European dermatology expert group consensus.
Boehncke WH, Brasie RA, Barker J, Chimenti S, Daudén E, de Rie M, Dubertret L, Giannetti A, Katsambas A, Kragballe K, Naeyaert JM, Ortonne JP, Peyrí J, Prinz JC, Saurat JH, Strohal R, van de Kerkhof P, Sterry W; European Dermatology Expert Group. Boehncke WH, et al. Among authors: strohal r. J Eur Acad Dermatol Venereol. 2006 Sep;20(8):988-98. doi: 10.1111/j.1468-3083.2006.01707.x. J Eur Acad Dermatol Venereol. 2006. PMID: 16922950
88 results